Aug. 7 at 9:08 PM
$COYA This was in just released 8k with Mark Paveo joining Coya board. Here is his bio I saw online.
Mark Pavao, Interim Chair and Treasurer
Managing Partner, Biotech Value Advisors
Mark Pavao has been a commercial leader in the global biopharma industry for 30+ years. Mark currently supports developing biotech companies with commercial and go-to-market strategy and tactical planning. Previous roles include President and CEO of R-Pharm US, President Bristol-Myers Squibb (BMS) / AstraZeneca Diabetes Alliance, President Emerging Markets Region at BMS, and SVP of Global Market Access and Pricing at BMS. Earlier, Mark held sales and marketing leadership roles at Bristol-Myers Squibb, SmithKline Beecham Pharmaceuticals, NitroMed Inc., and HeliosHealth. Mark has lived and/or worked in Brazil, Peru, Spain, Netherlands, Russia, India, China, Turkey, and the US. He received his MBA from Wharton and a BA from UNC-Chapel Hill, where he was a Morehead Scholar
